GlassScriptPhysician profile
Vrajesh Mehta
NPI 1235591033
$15,407.05
in general payments reported to CMS, 2019-2025
29 companies · $1,921 in 2025
The $1,921 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,101 · 2022: $7,451 · 2023: $2,066 · 2024: $2,868 · 2025: $1,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,582 · Food and Beverage: $3,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,581.85 |
| Food and Beverage | $3,272.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,188.22 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $2,585.05 | 2021-2025 | Eterna, Proclaim, Octrode |
| Medtronic, INC. | $2,491.55 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Genesys Orthopedics Systems, L.L.C. | $1,400.05 | 2022 | |
| Si-Bone, INC. | $1,212.93 | 2021-2024 | |
| Globus Medical, INC. | $1,134.30 | 2025 | Senza |
| Abbvie INC. | $517.13 | 2021-2025 | |
| Nevro Corp. | $434.30 | 2021-2024 | Senza |
| Stryker Corporation | $313.75 | 2021-2025 | Optablate, Mild Device Kit, Spinejack |
| Amgen INC. | $189.69 | 2022-2025 | Evenity, Prolia, Prolia |
| Painteq LLC | $121.20 | 2023-2024 | Painteq |
| Spr Therapeutics, INC | $113.10 | 2021 | |
| Radius Health, INC. | $100.83 | 2024-2025 | Tymlos |
| Allergan, INC. | $96.11 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $77.87 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $62.05 | 2021 | |
| Grt US Holding, INC. | $56.67 | 2021-2022 | |
| Saluda Medical Americas, INC. | $44.57 | 2024-2025 | Evoke |
| Biotronik Nro, INC. | $41.71 | 2024-2025 | Prospera |
| Lilly USA, LLC | $31.84 | 2021 | |
| Bioventus LLC | $29.41 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $29.37 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $25.82 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $23.66 | 2025 | |
| Averitas Pharma INC. | $21.96 | 2024 | Qutenza |
| Pacira Therapeutics, INC. | $19.69 | 2021 | |
| Emd Serono, INC. | $17.13 | 2021 | |
| Avanos Medical | $13.59 | 2021 | |
| Pfizer INC. | $13.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vrajesh Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.